Anthony Portale, MD
Professor
Pediatrics
School of Medicine

Education & Training

Show all (1) Hide

• Residency School of Medicine University of California, San Francisco

Websites

Show all (1) Hide

• Clinical Profile at UCSF Benioff Children's Hospital (ucsfbenioffchildrens.org)

Grants and Projects

Show all (5) Hide

• Disordered Mineral Metabolism in the CKiD Children: Role of FGF-23, NIH, 2010-2016
• Bio-Organic Biomedical Mass Spectrometry Resource, NIH, 1982-2015
• General Clinical Research Center, NIH, 1974-2009
• Pediatric Clinical Research Center, NIH, 1981-2007
• Molecular Regulation of 1,25(Oh)2D Production, NIH, 1998-2005

Publications (96)

Top publication keywords:
Phosphorus, DietarySteroid HydroxylasesVitamin D25-Hydroxyvitamin D3 1-alpha-HydroxylaseRenal Insufficiency, ChronicFibroblast Growth FactorsOsteomalaciaKidneyAntibodies, MonoclonalGenetic Diseases, X-LinkedRicketsFamilial Hypophosphatemic RicketsCalcitriolPhosphorusPhosphates

• Burosumab vs Phosphate/Active Vitamin D in Pediatric X-Linked Hypophosphatemia: A Subgroup Analysis by Dose Level.
  The Journal of clinical endocrinology and metabolism 2023 Imel EA, Glorieux FH, Whyte MP, Portale AA, Munns CF, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad …
• Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia.
  The Journal of clinical endocrinology and metabolism 2022 Weber TJ, Imel EA, Carpenter TO, Peacock M, Portale AA, Hetzer J, Merritt JL, Insogna K
• Efficacy of Burosumab in Adults with X-linked Hypophosphatemia (XLH): A Post Hoc Subgroup Analysis of a Randomized Double-Blind Placebo-Controlled Phase 3 Study.
  Calcified tissue international 2022 Brandi ML, Jan de Beur S, Briot K, Carpenter T, Cheong HI, Cohen-Solal M, Crowley RK, Eastell R, Imanishi Y, Imel EA, Ing SW, Insogna K, Ito N, Javaid K, Kamenicky P, Keen R, Kubota T, Lachmann RH, …
• Effect of Burosumab Compared With Conventional Therapy on Younger vs Older Children With X-linked Hypophosphatemia.
  The Journal of clinical endocrinology and metabolism 2022 Ward LM, Glorieux FH, Whyte MP, Munns CF, Portale AA, Högler W, Simmons JH, Gottesman GS, Padidela R, Namba N, Cheong HI, Nilsson O, Mao M, Chen A, Skrinar A, Roberts MS, Imel EA
• A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial.
  Pediatric nephrology (Berlin, Germany) 2022 Hanudel MR, Laster ML, Portale AA, Dokras A, Quigley RP, Guzman GAL, Zaritsky JJ, Hayde NA, Kaskel FJ, Mitsnefes MM, Ramirez JA, Imani PD, Srivaths PR, Kogon AJ, Denburg MR, Blydt-Hansen TD, Reyes LZ,…

Show all (91 more) Hide

• Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia.
  The Journal of clinical endocrinology and metabolism 2022 Linglart A, Imel EA, Whyte MP, Portale AA, Högler W, Boot AM, Padidela R, Van't Hoff W, Gottesman GS, Chen A, Skrinar A, Scott Roberts M, Carpenter TO
• Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension.
  RMD open 2021 Briot K, Portale AA, Brandi ML, Carpenter TO, Cheong HI, Cohen-Solal M, Crowley RK, Eastell R, Imanishi Y, Ing S, Insogna K, Ito N, Jan de Beur S, Javaid MK, Kamenicky P, Keen R, Kubota T, Lachmann RH…
• Patient-Reported Outcomes from a Randomized, Active-Controlled, Open-Label, Phase 3 Trial of Burosumab Versus Conventional Therapy in Children with X-Linked Hypophosphatemia.
  Calcified tissue international 2021 Padidela R, Whyte MP, Glorieux FH, Munns CF, Ward LM, Nilsson O, Portale AA, Simmons JH, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad …
• Association Between Chronic Kidney Disease-Mineral Bone Disease (CKD-MBD) and Cognition in Children: Chronic Kidney Disease in Children (CKiD) Study.
  Kidney medicine 2020 Yokoyama JS, Matsuda-Abedini M, Denburg MR, Kumar J, Warady BA, Furth SL, Hooper SR, Portale AA, Perwad F
• Burosumab Improved Histomorphometric Measures of Osteomalacia in Adults with X-Linked Hypophosphatemia: A Phase 3, Single-Arm, International Trial.
  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2019 Insogna KL, Rauch F, Kamenický P, Ito N, Kubota T, Nakamura A, Zhang L, Mealiffe M, San Martin J, Portale AA
• Burosumab Therapy for X-Linked Hypophosphatemia and Therapeutic Implications for CKD.
  Clinical journal of the American Society of Nephrology : CJASN 2019 Perwad F, Portale AA
• Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.
  Calcified tissue international 2019 Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, …
• Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
  Lancet (London, England) 2019 Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Högler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, …
• Correction to: An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.
  Pediatric nephrology (Berlin, Germany) 2019 Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA
• An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28 days to < 6 years with chronic kidney disease receiving dialysis.
  Pediatric nephrology (Berlin, Germany) 2018 Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA
• Vitamin D insufficiency, hemoglobin, and anemia in children with chronic kidney disease.
  Pediatric nephrology (Berlin, Germany) 2018 Altemose KE, Kumar J, Portale AA, Warady BA, Furth SL, Fadrowski JJ, Atkinson MA
• A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis.
  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018 Insogna KL, Briot K, Imel EA, Kamenický P, Ruppe MD, Portale AA, Weber T, Pitukcheewanont P, Cheong HI, Jan de Beur S, Imanishi Y, Ito N, Lachmann RH, Tanaka H, Perwad F, Zhang L, Chen CY, Theodore-…
• Waist-to-height ratio, body mass index, and cardiovascular risk profile in children with chronic kidney disease.
  Pediatric nephrology (Berlin, Germany) 2018 Sgambat K, Roem J, Mitsnefes M, Portale AA, Furth S, Warady B, Moudgil A
• Burosumab Therapy in Children with X-Linked Hypophosphatemia.
  The New England journal of medicine 2018 Carpenter TO, Whyte MP, Imel EA, Boot AM, Högler W, Linglart A, Padidela R, Van't Hoff W, Mao M, Chen CY, Skrinar A, Kakkis E, San Martin J, Portale AA
• Time-varying coefficient of determination to quantify the explanatory power of biomarkers on longitudinal GFR among children with chronic kidney disease.
  Annals of epidemiology 2018 Ng DK, Portale AA, Furth SL, Warady BA, Muñoz A
• Rickets.
  Nature reviews. Disease primers 2017 Carpenter TO, Shaw NJ, Portale AA, Ward LM, Abrams SA, Pettifor JM
• FGF23 and Left Ventricular Hypertrophy in Children with CKD.
  Clinical journal of the American Society of Nephrology : CJASN 2017 Mitsnefes MM, Betoko A, Schneider MF, Salusky IB, Wolf MS, Jüppner H, Warady BA, Furth SL, Portale AA
• Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
  Clinical journal of the American Society of Nephrology : CJASN 2016 Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB
• Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia.
  Bone reports 2016 Ruppe MD, Zhang X, Imel EA, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey JS, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO
• Effect of Immigration Status on Outcomes in Pediatric Kidney Transplant Recipients.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2016 McEnhill ME, Brennan JL, Winnicki E, Lee MM, Tavakol M, Posselt AM, Stock PG, Portale AA
• Characterization of FGF23-Dependent Egr-1 Cistrome in the Mouse Renal Proximal Tubule.
  PloS one 2015 Portale AA, Zhang MY, David V, Martin A, Jiao Y, Gu W, Perwad F
• Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.
  Pediatric nephrology (Berlin, Germany) 2015 Kumar J, McDermott K, Abraham AG, Friedman LA, Johnson VL, Kaskel FJ, Furth SL, Warady BA, Portale AA, Melamed ML
• Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.
  Journal of clinical pharmacology 2015 Zhang X, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey J, Glorieux FH, Portale AA, Insogna K, Carpenter TO, Peacock M
• Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study.
  Journal of the American Society of Nephrology : JASN 2015 Denburg MR, Kumar J, Jemielita T, Brooks ER, Skversky A, Portale AA, Salusky IB, Warady BA, Furth SL, Leonard MB
• Association of Body Mass Index with Patient-Centered Outcomes in Children with ESRD.
  Journal of the American Society of Nephrology : JASN 2015 Ku E, Glidden DV, Hsu CY, Portale AA, Grimes B, Johansen KL
• Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23.
  The Journal of clinical endocrinology and metabolism 2015 Imel EA, Zhang X, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey JS, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO
• State level variations in nephrology workforce and timing and incidence of dialysis in the United States among children and adults: a retrospective cohort study.
  BMC nephrology 2015 Ku E, Johansen KL, Portale AA, Grimes B, Hsu CY
• Malcolm A. Holliday, M.D, January 12, 1924 - March 26, 2014.
  Pediatric nephrology (Berlin, Germany) 2014 Wassner SJ, Chesney RW, Friedman A, Chantler C, Portale AA
• Use of pedometers to increase physical activity among children and adolescents with chronic kidney disease.
  Pediatric nephrology (Berlin, Germany) 2014 Akber A, Portale AA, Johansen KL
• Disordered FGF23 and mineral metabolism in children with CKD.
  Clinical journal of the American Society of Nephrology : CJASN 2013 Portale AA, Wolf M, Jüppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB
• FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues.
  PloS one 2013 Chanakul A, Zhang MY, Louw A, Armbrecht HJ, Miller WL, Portale AA, Perwad F
• Combined pancreatic islet and kidney transplantation in a child with unstable type 1 diabetes and end-stage renal disease.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2013 Benedict KA, Moassesfar S, Adi S, Gitelman SE, Brennan JL, McEnhill M, Stock PG, Portale AA, Posselt AM
• Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone.
  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2013 Park-Sigal J, Don BR, Porzig A, Recker R, Griswold V, Sebastian A, Duh QY, Portale AA, Shoback D, Schambelan M
• The clinical impact of humoral immunity in pediatric renal transplantation.
  Journal of the American Society of Nephrology : JASN 2013 Chaudhuri A, Ozawa M, Everly MJ, Ettenger R, Dharnidharka V, Benfield M, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Li L, Sigdel TK, Hsieh SC,…
• A peripheral blood diagnostic test for acute rejection in renal transplantation.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Li L, Khatri P, Sigdel TK, Tran T, Ying L, Vitalone MJ, Chen A, Hsieh S, Dai H, Zhang M, Naesens M, Zarkhin V, Sansanwal P, Chen R, Mindrinos M, Xiao W, Benfield M, Ettenger RB, Dharnidharka V, …
• Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up.
  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012 Sarwal MM, Ettenger RB, Dharnidharka V, Benfield M, Mathias R, Portale A, McDonald R, Harmon W, Kershaw D, Vehaskari VM, Kamil E, Baluarte HJ, Warady B, Tang L, Liu J, Li L, Naesens M, Sigdel T, …
• Pedometer-assessed physical activity in children and young adults with CKD.
  Clinical journal of the American Society of Nephrology : CJASN 2012 Akber A, Portale AA, Johansen KL
• Chronic inhibition of ERK1/2 signaling improves disordered bone and mineral metabolism in hypophosphatemic (Hyp) mice.
  Endocrinology 2012 Zhang MY, Ranch D, Pereira RC, Armbrecht HJ, Portale AA, Perwad F
• Vitamin D metabolism in the kidney: regulation by phosphorus and fibroblast growth factor 23.
  Molecular and cellular endocrinology 2011 Perwad F, Portale AA
• Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice.
  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2011 Ranch D, Zhang MY, Portale AA, Perwad F
• Emerging topics in pediatric bone and mineral disorders 2008.
  Seminars in nephrology 2009 McKay CP, Portale A
• Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents.
  Pediatrics 2008 Nguyen S, McCulloch C, Brakeman P, Portale A, Hsu CY
• Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro.
  American journal of physiology. Renal physiology 2007 Perwad F, Zhang MY, Tenenhouse HS, Portale AA
• Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency.
  The Journal of clinical endocrinology and metabolism 2007 Kim CJ, Kaplan LE, Perwad F, Huang N, Sharma A, Choi Y, Miller WL, Portale AA
• Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.
  The Journal of clinical endocrinology and metabolism 2006 Antoniucci DM, Yamashita T, Portale AA
• Persistent secondary hyperparathyroidism after renal transplantation in children.
  Pediatric nephrology (Berlin, Germany) 2005 Matsuda-Abedini M, Portale AA, Shah A, Neuhaus J, McEnhill M, Mathias RS
• Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice.
  Endocrinology 2005 Perwad F, Azam N, Zhang MY, Yamashita T, Tenenhouse HS, Portale AA
• Nephrogenic syndrome of inappropriate antidiuresis.
  The New England journal of medicine 2005 Feldman BJ, Rosenthal SM, Vargas GA, Fenwick RG, Huang EA, Matsuda-Abedini M, Lustig RH, Mathias RS, Portale AA, Miller WL, Gitelman SE
• Disordered regulation of renal 25-hydroxyvitamin D-1alpha-hydroxylase gene expression by phosphorus in X-linked hypophosphatemic (hyp) mice.
  Endocrinology 2003 Azam N, Zhang MY, Wang X, Tenenhouse HS, Portale AA
• Vitamin D biosynthesis and vitamin D 1 alpha-hydroxylase deficiency.
  Endocrine development 2003 Miller WL, Portale AA
• Dietary phosphorus transcriptionally regulates 25-hydroxyvitamin D-1alpha-hydroxylase gene expression in the proximal renal tubule.
  Endocrinology 2002 Zhang MY, Wang X, Wang JT, Compagnone NA, Mellon SH, Olson JL, Tenenhouse HS, Miller WL, Portale AA
• Genetics of vitamin D biosynthesis and its disorders.
  Best practice & research. Clinical endocrinology & metabolism 2001 Miller WL, Portale AA
• Renal expression of the sodium/phosphate cotransporter gene, Npt2, is not required for regulation of renal 1 alpha-hydroxylase by phosphate.
  Endocrinology 2001 Tenenhouse HS, Martel J, Gauthier C, Zhang MY, Portale AA
• Vitamin D 1 alpha-hydroxylase.
  Trends in endocrinology and metabolism: TEM 2000 Miller WL, Portale AA
• Human 25-hydroxyvitamin D-1alpha-hydroxylase: cloning, mutations, and gene expression.
  Pediatric nephrology (Berlin, Germany) 2000 Portale AA, Miller WL
• Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition.
  The American journal of clinical nutrition 2000 Goodman WG, Misra S, Veldhuis JD, Portale AA, Wang HJ, Ament ME, Salusky IB
• Genetic disorders of vitamin D biosynthesis.
  Endocrinology and metabolism clinics of North America 1999 Miller WL, Portale AA
• Genetic causes of rickets.
  Current opinion in pediatrics 1999 Miller WL, Portale AA
• Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
  Kidney international 1999 Hoppe B, Kemper MJ, Bökenkamp A, Portale AA, Cohn RA, Langman CB
• Genetics of vitamin D 1alpha-hydroxylase deficiency in 17 families.
  American journal of human genetics 1998 Wang JT, Lin CJ, Burridge SM, Fu GK, Labuda M, Portale AA, Miller WL
• Hereditary rickets revealed.
  Kidney international 1998 Portale AA, Miller WL
• Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency.
  Journal of the American Society of Nephrology : JASN 1998 Mathias RS, Nguyen HT, Zhang MY, Portale AA
• Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1.
  Molecular endocrinology (Baltimore, Md.) 1997 Fu GK, Lin D, Zhang MY, Bikle DD, Shackleton CH, Miller WL, Portale AA
• Complete structure of the human gene for the vitamin D 1alpha-hydroxylase, P450c1alpha.
  DNA and cell biology 1997 Fu GK, Portale AA, Miller WL
• Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men.
  The American journal of physiology 1997 Portale AA, Lonergan ET, Tanney DM, Halloran BP
• Aging and renal responsiveness to parathyroid hormone in healthy men.
  The Journal of clinical endocrinology and metabolism 1996 Halloran BP, Lonergan ET, Portale AA
• Effect of aging on the metabolism of phosphorus and 1,25-dihydroxyvitamin D in healthy men.
  The American journal of physiology 1996 Portale AA, Halloran BP, Morris RC, Lonergan ET
• Resolution of hepatitis B virus-related membranoproliferative glomerulonephritis after orthotopic liver transplantation.
  Pediatric nephrology (Berlin, Germany) 1995 Quan A, Portale A, Foster S, Lavine J
• Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation.
  Transplantation 1995 Sorof JM, Koerper MA, Portale AA, Potter D, DeSantes K, Cowan M
• Acute post-streptococcal glomerulonephritis in a renal allograft.
  Pediatric nephrology (Berlin, Germany) 1995 Sorof JM, Weidner N, Potter D, Portale AA
• Metabolic acidosis reverses the increase in serum 1,25(OH)2D in phosphorus-restricted normal men.
  The American journal of physiology 1992 Portale AA, Halloran BP, Harris ST, Bikle DD, Morris RC
• Progestin antagonism of estrogen stimulated 1,25-dihydroxyvitamin D levels.
  The Journal of clinical endocrinology and metabolism 1992 Bikle DD, Halloran BP, Harris ST, Portale AA
• Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism.
  The Journal of clinical endocrinology and metabolism 1991 Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA
• Are blood transfusions beneficial in the cyclosporine era?
  Pediatric nephrology (Berlin, Germany) 1991 Potter DE, Portale AA, Melzer JS, Feduska NJ, Garovoy MR, Husing RM, Salvatierra O
• Pathogenesis of secondary hyperparathyroidism in chronic renal insufficiency.
  Mineral and electrolyte metabolism 1991 Portale AA, Morris RC
• Dietary potassium influences kidney maintenance of serum phosphorus concentration.
  Kidney international 1990 Sebastian A, Hernandez RE, Portale AA, Colman J, Tatsuno J, Morris RC
• Production and metabolic clearance of 1,25-dihydroxyvitamin D in men: effect of advancing age.
  The Journal of clinical endocrinology and metabolism 1990 Halloran BP, Portale AA, Lonergan ET, Morris RC
• Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men.
  The Journal of clinical investigation 1989 Portale AA, Halloran BP, Morris RC
• Pregnancy complicated by maternal spina bifida. A report of two cases.
  The Journal of reproductive medicine 1988 Farine D, Jackson U, Portale A, Baxi L, Fox HE
• Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D.
  The Journal of clinical investigation 1987 Portale AA, Halloran BP, Morris RC
• Evidence for a difference in vitamin D metabolism between spontaneously hypertensive and Wistar-Kyoto rats.
  Hypertension (Dallas, Tex. : 1979) 1986 Kurtz TW, Portale AA, Morris RC
• Comparison of continuous ambulatory peritoneal dialysis and hemodialysis in children.
  Kidney international. Supplement 1986 Potter DE, San Luis E, Wipfler JE, Portale AA
• Liquid-chromatographic measurements of inosine, hypoxanthine, and xanthine in studies of fructose-induced degradation of adenine nucleotides in humans and rats.
  Clinical chemistry 1986 Kurtz TW, Kabra PM, Booth BE, Al-Bander HA, Portale AA, Serena BG, Tsai HC, Morris RC
• Renal osteodystrophy in children: the role of vitamin D, phosphorus, and parathyroid hormone.
  American journal of kidney diseases : the official journal of the National Kidney Foundation 1986 Chesney RW, Mehls O, Anast CS, Brown E, Hammerman MR, Portale A, Fallon MD, Mahan J, Alfrey AC
• Oral intake of phosphorus can determine the serum concentration of 1,25-dihydroxyvitamin D by determining its production rate in humans.
  The Journal of clinical investigation 1986 Portale AA, Halloran BP, Murphy MM, Morris RC
• Serum concentration of 1,25-dihydroxyvitamin D in the human: diurnal variation.
  The Journal of clinical endocrinology and metabolism 1985 Halloran BP, Portale AA, Castro M, Morris RC, Goldsmith RS
• Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency.
  The Journal of clinical investigation 1984 Portale AA, Booth BE, Halloran BP, Morris RC
• Hemoperfusion in a child who ingested diquat and died from pontine infarction and hemorrhage.
  Journal of toxicology. Clinical toxicology 1983 Powell D, Pond SM, Allen TB, Portale AA
• Reduced plasma concentration of 1,25-dihydroxyvitamin D in children with moderate renal insufficiency.
  Kidney international 1982 Portale AA, Booth BE, Tsai HC, Morris RC
• [Clinical study of the effects of metisoprinol in the treatment of mumps in adults].
  La Clinica terapeutica 1980 Galvagna S, Rosella PP, Portale A
• Nutritional management of chronic renal disease.
  The Medical clinics of North America 1979 Holliday MA, McHenry-Richardson K, Portale A